October 2, 2012 12:12 am by Kelly, Susan | 0 Comments
CHICAGO (Reuters) - Venture capitalists, long the lifeblood of medical technology firms, are growing cautious on the sector after seeing their returns squeezed in a time of growing cost pressures ...
Read more